Alpha-fetoprotein impairs APC function and induces their apoptosis.

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Alpha-fetoprotein (AFP) is a tumor marker elevated in hepatocellular carcinoma (HCC).
• Elevated AFP levels in HCC patients are associated with impaired anti-tumor immunity.
• Dendritic cells (DCs) play a crucial role in initiating anti-tumor immune responses.

Purpose of the Study:

• To investigate the direct effects of AFP on immune cells, specifically DCs and antigen-presenting cells (APCs).
• To elucidate the mechanisms by which AFP may contribute to HCC immune evasion.

Main Methods:

• In vitro studies exposing DCs to AFP to assess functional and apoptotic changes.
• Analysis of cell surface molecule expression (CD40, CD86) on DCs.
• Measurement of cytokine production (IL-12, TNF-alpha) by DCs.
• Ex vivo analysis of APCs from HCC patients with high AFP levels.

Main Results:

• In vitro, AFP induced down-regulation of CD40 and CD86 on DCs, impairing their allostimulatory function.
• AFP significantly induced apoptosis (programmed cell death) in DCs.
• AFP-treated DCs produced reduced levels of IL-12 and TNF-alpha, crucial cytokines for anti-tumor immunity.
• Ex vivo, APCs from HCC patients with high AFP showed lower TNF-alpha production compared to healthy individuals.

Conclusions:

• AFP directly induces functional impairment and apoptosis of DCs.
• AFP alters cytokine production in immune cells, potentially hindering effective anti-tumor immune responses.
• These findings suggest a mechanism by which HCC, via elevated AFP, escapes immunological surveillance and control.